These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28174043)

  • 1. Sodium influx through cerebral sodium-glucose transporter type 1 exacerbates the development of cerebral ischemic neuronal damage.
    Yamazaki Y; Harada S; Wada T; Hagiwara T; Yoshida S; Tokuyama S
    Eur J Pharmacol; 2017 Mar; 799():103-110. PubMed ID: 28174043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium transport through the cerebral sodium-glucose transporter exacerbates neuron damage during cerebral ischaemia.
    Yamazaki Y; Harada S; Wada T; Yoshida S; Tokuyama S
    J Pharm Pharmacol; 2016 Jul; 68(7):922-31. PubMed ID: 27139580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of cerebral sodium-glucose transporter type 1 function mediated by post-ischemic hyperglycemia exacerbates the development of cerebral ischemia.
    Yamazaki Y; Ogihara S; Harada S; Tokuyama S
    Neuroscience; 2015 Dec; 310():674-85. PubMed ID: 26454021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium-glucose transporter type 3-mediated neuroprotective effect of acetylcholine suppresses the development of cerebral ischemic neuronal damage.
    Yamazaki Y; Harada S; Tokuyama S
    Neuroscience; 2014 Jun; 269():134-42. PubMed ID: 24699226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between cerebral sodium-glucose transporter and hyperglycemia in cerebral ischemia.
    Yamazaki Y; Harada S; Tokuyama S
    Neurosci Lett; 2015 Sep; 604():134-9. PubMed ID: 26254165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Potential of the Cerebral Sodium-Glucose Transporter as a Novel Therapeutic Target in Cerebral Ischemia].
    Yamazaki Y; Harada S; Tokuyama S
    Yakugaku Zasshi; 2018; 138(7):955-962. PubMed ID: 29962475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporter.
    Yamazaki Y; Harada S; Tokuyama S
    Brain Res; 2012 Dec; 1489():113-20. PubMed ID: 23078759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect through the cerebral sodium-glucose transporter on the development of ischemic damage in global ischemia.
    Harada S; Yamazaki Y; Nishioka H; Tokuyama S
    Brain Res; 2013 Dec; 1541():61-8. PubMed ID: 24134951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of c-Jun N-terminal kinase and p38 after cerebral ischemia upregulates cerebral sodium-glucose transporter type 1.
    Yamazaki Y; Arita K; Harada S; Tokuyama S
    J Pharmacol Sci; 2018 Dec; 138(4):240-246. PubMed ID: 30503674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Na(+)-dependent chloride transporter (NKCC1)-null mice exhibit less gray and white matter damage after focal cerebral ischemia.
    Chen H; Luo J; Kintner DB; Shull GE; Sun D
    J Cereb Blood Flow Metab; 2005 Jan; 25(1):54-66. PubMed ID: 15678112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium-glucose transporter as a novel therapeutic target in disease.
    Yamazaki Y; Harada S; Tokuyama S
    Eur J Pharmacol; 2018 Mar; 822():25-31. PubMed ID: 29329760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation.
    Vemula S; Roder KE; Yang T; Bhat GJ; Thekkumkara TJ; Abbruscato TJ
    J Pharmacol Exp Ther; 2009 Feb; 328(2):487-95. PubMed ID: 18981287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of microRNA-134 on neural cell survival against ischemic injury in primary cultured neuronal cells and mouse brain with ischemic stroke by targeting HSPA12B.
    Chi W; Meng F; Li Y; Li P; Wang G; Cheng H; Han S; Li J
    Brain Res; 2014 Dec; 1592():22-33. PubMed ID: 25304362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterisation of human SGLT-5 as a novel kidney-specific sodium-dependent sugar transporter.
    Grempler R; Augustin R; Froehner S; Hildebrandt T; Simon E; Mark M; Eickelmann P
    FEBS Lett; 2012 Feb; 586(3):248-53. PubMed ID: 22212718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucosamine-induced Sp1 O-GlcNAcylation ameliorates hypoxia-induced SGLT dysfunction in primary cultured renal proximal tubule cells.
    Suh HN; Lee YJ; Kim MO; Ryu JM; Han HJ
    J Cell Physiol; 2014 Oct; 229(10):1557-68. PubMed ID: 24591095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of BSA-induced ER stress on SGLT protein expression levels and alpha-MG uptake in renal proximal tubule cells.
    Lee YJ; Suh HN; Han HJ
    Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1405-16. PubMed ID: 19211687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage.
    Harada S; Fujita WH; Shichi K; Tokuyama S
    Brain Res; 2009 Jul; 1279():174-81. PubMed ID: 19445903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons.
    Yamashita K; Kotani Y; Nakajima Y; Shimazawa M; Yoshimura S; Nakashima S; Iwama T; Hara H
    Brain Res; 2007 Jun; 1154():215-24. PubMed ID: 17482584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orexin-A suppresses postischemic glucose intolerance and neuronal damage through hypothalamic brain-derived neurotrophic factor.
    Harada S; Yamazaki Y; Tokuyama S
    J Pharmacol Exp Ther; 2013 Jan; 344(1):276-85. PubMed ID: 23117790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia.
    Zhang W; Potrovita I; Tarabin V; Herrmann O; Beer V; Weih F; Schneider A; Schwaninger M
    J Cereb Blood Flow Metab; 2005 Jan; 25(1):30-40. PubMed ID: 15678110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.